- Home
- CMND vs LIPO Comparison
CMND vs LIPO Comparison
Compare CMND & LIPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMND
- LIPO
- Stock Information
- Founded
- CMND 2017
- LIPO 2005
- Country
- CMND Canada
- LIPO United States
- Employees
- CMND N/A
- LIPO N/A
- Industry
- CMND Biotechnology: Pharmaceutical Preparations
- LIPO Biotechnology: Pharmaceutical Preparations
- Sector
- CMND Health Care
- LIPO Health Care
- Exchange
- CMND Nasdaq
- LIPO Nasdaq
- Market Cap
- CMND 5.3M
- LIPO 3.4M
- IPO Year
- CMND N/A
- LIPO 2022
- Fundamental
- Price
- CMND $1.28
- LIPO $0.51
- Analyst Decision
- CMND
- LIPO Strong Buy
- Analyst Count
- CMND 0
- LIPO 1
- Target Price
- CMND N/A
- LIPO $2.00
- AVG Volume (30 Days)
- CMND 480.8K
- LIPO 441.3K
- Earning Date
- CMND 09-17-2024
- LIPO 08-13-2024
- Dividend Yield
- CMND N/A
- LIPO N/A
- EPS Growth
- CMND N/A
- LIPO N/A
- EPS
- CMND N/A
- LIPO N/A
- Revenue
- CMND N/A
- LIPO $507,204.00
- Revenue This Year
- CMND N/A
- LIPO N/A
- Revenue Next Year
- CMND N/A
- LIPO N/A
- P/E Ratio
- CMND N/A
- LIPO N/A
- Revenue Growth
- CMND N/A
- LIPO 34.99
- 52 Week Low
- CMND $0.92
- LIPO $0.32
- 52 Week High
- CMND $13.77
- LIPO $2.71
- Technical
- Relative Strength Index (RSI)
- CMND 46.21
- LIPO 54.49
- Support Level
- CMND $1.21
- LIPO $0.38
- Resistance Level
- CMND $1.31
- LIPO $0.44
- Average True Range (ATR)
- CMND 0.12
- LIPO 0.07
- MACD
- CMND 0.01
- LIPO 0.01
- Stochastic Oscillator
- CMND 56.41
- LIPO 76.76
About CMND Clearmind Medicine Inc.
Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.
About LIPO Lipella Pharmaceuticals Inc.
Lipella Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is focused on developing new drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for new applications. The company's product candidates include LP-10, LP-310 and LP-410 which can be helpful in treatment of Hemorrahagic Cystitis, Oral Licen Planus and Oral Graft.